The Indian Supreme Court’s rejection of Novartis’s Glivec patent brought the increasingly tense debate about the balance between patent rights and access to medicines to the forefront. Anand Grover, ...

I recently caught up with Rishi Grover, Chief Solutions Architect at Vena Solutions, to examine the way analytics technologies are helping corporate finance teams move from traditional, manual ways of ...